| Patient | HMGCR Titer prior to RTX, AU/ml (timing) | HMGCR Titer after RTX, AU/ml (timing) | RTX Response |
|---|---|---|---|
| A | 1597 (M–1) | 63.8 (M18) | Success |
| C | 107.9 (M–2) | 105.4 (M12) | Success |
| D | 114.6 (D0) | 134.5 (M9) | Failure |
| F | 235.5 (D0) | 276.5 (M4) | Failure |
Anti-HMGCR: anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase; RTX: rituximab; D0: baseline; M–1: 1 month prior; M–2: 2 months prior; M4: 4 months after; M9: 9 months after; M12: 12 months after; M18: 18 months after.